#FDAclearance
LightNews LightNews
virgobit.bsky.social
🚀FDA clears Fasikl’s AI-powered wristband for essential tremor — no surgery or pills needed.

The Felix NeuroAI Wristband delivers real-time, personalized neurostimulation to reduce tremors — noninvasively.

Clinically proven in 125-patient trial.
#Neurotech #FDAclearance
July 10, 2025 at 10:07 AM
fazencapital.bsky.social
Stereotaxis Wins FDA Clearance for Synchrony System: Stereotaxis cleared by FDA on Apr 6, 2026; STXS stock moved up ~8% intraday. Synchrony targets the U.S. ablation market with ~100k–150k annual AF procedures. 👈 Read full analysis #Stereotaxis #FDAClearance #SynchronySystem #CatheterAblation #STXS
Stereotaxis Wins FDA Clearance for Synchrony System
Stereotaxis cleared by FDA on Apr 6, 2026; STXS stock moved up ~8% intraday. Synchrony targets the U.S. ablation market with ~100k–150k annual AF procedures.
dlvr.it
April 6, 2026 at 12:56 PM
fazencapital.bsky.social
GE HealthCare Cleared for Photonova Spectra CT: GE HealthCare (GEHC) received FDA 510(k) clearance on Apr 5, 2026 for Photonova Spectra CT; vendors cite up to 60% dose reduction and significant… 👈 Read full analysis #GEHealthCare #PhotonovaSpectraCT #FDAClearance #HealthcareTechnology #DoseReduction
GE HealthCare Cleared for Photonova Spectra CT
GE HealthCare (GEHC) received FDA 510(k) clearance on Apr 5, 2026 for Photonova Spectra CT; vendors cite up to 60% dose reduction and significant long-term service revenue potential.
dlvr.it
April 5, 2026 at 7:49 PM
fazencapital.bsky.social
Lantern Pharma FDA Clears Pediatric Trial: Lantern Pharma won FDA clearance on Mar 27, 2026 to start a Phase 1 pediatric DIPG trial; DIPG carries median survival under 12 months and ~200–400 US cases/year. 👈 Read full analysis #LanternPharma #FDAClearance #PediatricTrial #DIPG #ClinicalResearch
Lantern Pharma FDA Clears Pediatric Trial
Lantern Pharma won FDA clearance on Mar 27, 2026 to start a Phase 1 pediatric DIPG trial; DIPG carries median survival under 12 months and ~200–400 US cases/year.
dlvr.it
March 27, 2026 at 12:05 PM
d-and-d-world.bsky.social
RapidAI gains FDA clearance for 5 new clinical AI modules, expanding its platform to advance stroke, neurology, and vascular care.

#News #AI #HealthTech #FDA #Radiology #Stroke #Innovation #FDAclearance #AIimaging
RapidAI wins FDA nod for five new AI tools
RapidAI bolsters its clinical AI platform with new FDA-cleared modules designed to enhance neurology, vascular, and radiology care.
druganddeviceworld.com
November 26, 2025 at 10:24 AM
d-and-d-world.bsky.social
Rapid Nexus secures FDA clearance for Hemastyl, the first device targeting periwound tissue to improve chronic wound healing and reduce amputations. A major step forward in advanced wound care innovation.
#News #FDAclearance #MedTech #WoundCare #HealthcareInnovation #RapidNexus
Rapid Nexus earns FDA clearance for first wound healing device
California med-tech firm Rapid Nexus secures FDA clearance for Hemastyl, a device targeting the root cause of chronic non-healing wounds.
druganddeviceworld.com
November 19, 2025 at 10:45 AM
profittradingusa.bsky.social
Click Subscribe. #Alzheimers #BloodTest #FDAClearance #HealthcareInnovation #MedicalBreakthrough
www.investing.com
May 16, 2025 at 6:34 PM
phalguniddw.bsky.social
RapidAI gains FDA clearance for 5 new clinical AI modules, expanding its platform to advance stroke, neurology, and vascular care.

#News #AI #HealthTech #FDA #Radiology #Stroke #Innovation #FDAclearance #AIimaging
RapidAI wins FDA nod for five new AI tools
RapidAI bolsters its clinical AI platform with new FDA-cleared modules designed to enhance neurology, vascular, and radiology care.
druganddeviceworld.com
November 26, 2025 at 10:23 AM
phalguniddw.bsky.social
Rapid Nexus secures FDA clearance for Hemastyl, the first device targeting periwound tissue to improve chronic wound healing and reduce amputations. A major step forward in advanced wound care innovation.
#News #FDAclearance #MedTech #WoundCare #HealthcareInnovation #RapidNexus
Rapid Nexus earns FDA clearance for first wound healing device
California med-tech firm Rapid Nexus secures FDA clearance for Hemastyl, a device targeting the root cause of chronic non-healing wounds.
druganddeviceworld.com
November 19, 2025 at 10:45 AM
kstrategyand.bsky.social
Movano Health Receives FDA Clearance for EvieMED Ring, Opening New Avenues for Health Monitoring

www.linkedin.com/pulse/movano...

kstrategyand.com/digital-heal...

#FDAclearance #EvieMEDRing #Humanteconomy #Humantec
Movano Health Receives FDA Clearance for EvieMED Ring, Opening New Avenues for Health Monitoring
Movano Health (Nasdaq: MOVE) has achieved a significant milestone with the U.S.
www.linkedin.com
December 10, 2024 at 12:59 PM